Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis

N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar… - The Lancet, 2018 - thelancet.com
Background Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed
to estimate the association of treatment success and death with the use of individual drugs …

Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised …

F von Groote-Bidlingmaier, R Patientia… - The Lancet …, 2019 - thelancet.com
Background Delamanid is one of two recently approved drugs for the treatment of multidrug-
resistant tuberculosis. We aimed to evaluate the safety and efficacy of delamanid in the first …

Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis

JP Samuels, A Sood, JR Campbell, F Ahmad Khan… - Scientific reports, 2018 - nature.com
Little is known about the impact of comorbidities on multidrug resistant (MDR) and
extensively drug resistant (XDR) tuberculosis (TB) treatment outcomes. We aimed to …

Profile of delamanid for the treatment of multidrug-resistant tuberculosis

JD Szumowski, JB Lynch - Drug design, development and therapy, 2015 - Taylor & Francis
New approaches to the treatment of multidrug-resistant and extensively drug-resistant
tuberculosis (TB) are badly needed. Not only is the success rate of current treatment …

Predictors of early and interim culture un-conversion in multidrug-resistant/rifampicin-resistant tuberculosis: a retrospective multi-center cohort study in China

Q Chen, W He, J Du, W Kang, L Zou, X Tang… - … Resistance & Infection …, 2024 - Springer
Background We aimed to evaluate the predictors for early and interim culture conversion
within 2 months and 6 months of treatment in multidrug-resistant/rifampicin-resistant …

Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study

M El Hamdouni, JE Bourkadi, J Benamor… - BMC infectious …, 2019 - Springer
Background Drug resistant tuberculosis is a major public health problem in Morocco and
worldwide. Treatment outcome of drug resistant tuberculosis is poor and requires a long …

Management and treatment outcomes of MDR-TB: results from a setting with high rates of drug resistance

N Ahmad, A Javaid, A Basit, AK Afridi… - … of Tuberculosis and …, 2015 - ingentaconnect.com
SETTINGS: Although Pakistan has a high burden of multidrug-resistant tuberculosis (MDR-
TB), little is known about the management and treatment outcomes of MDR-TB patients in …

[HTML][HTML] Evaluation of treatment outcomes and factors associated with unsuccessful outcomes in multidrug resistant tuberculosis patients in Baluchistan province of …

I Khan, N Ahmad, S Khan, S Muhammad… - Journal of infection and …, 2019 - Elsevier
Background Evaluating treatment outcomes of a cohort of patients is an effective way for
analyzing the effectiveness of a program. Information regarding drug resistance pattern …

Association between directly observed therapy and treatment outcomes in multidrug-resistant tuberculosis: a systematic review and meta-analysis

J Yin, J Yuan, Y Hu, X Wei - PloS one, 2016 - journals.plos.org
Background Multidrug-resistant tuberculosis (MDR-TB) represents a major obstacle towards
successful TB control. Directly observed therapy (DOT) was recommended by WHO to …

Predictors of unsuccessful interim treatment outcomes of multidrug resistant tuberculosis patients

M Atif, A Bashir, N Ahmad, RK Fatima, S Saba… - BMC infectious …, 2017 - Springer
Background Interim treatment outcomes at 6-months for multidrug-resistant tuberculosis
(MDR-TB) treatment are among the most basic performance monitoring and key evaluation …